Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study

We aimed to test the efficacy and toxicity of autologous hematopoietic cell transplant (HCT) in Multiple Myeloma (MM) patients aged ≥65 years compared to patients aged 60–64. Two hundred twenty consecutive patients (age ≥65, n = 87) with MM aged 60 and above, who underwent HCT as part of an upfront...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2017-02, Vol.96 (2), p.271-278
Hauptverfasser:	Cohen, Yael C, Zuckerman, Tsila, Yeshurun, Moshe, Perez, Galit, Magen, Hila, Henig, Israel, Levi, Itai, Shargian, Liat, Trestman, Svetlana, Rouvio, Uri, Naparstek, Elizabeth, Ganon-Elazar, Eti, Avivi, Irit, Ram, Ron
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cohort Studies Female Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - mortality Hematopoietic Stem Cell Transplantation - trends Humans Israel - epidemiology Male Medicine Medicine & Public Health Middle Aged Multiple Myeloma - diagnosis Multiple Myeloma - mortality Multiple Myeloma - therapy Oncology Original Article Retrospective Studies Survival Rate - trends Transplantation Conditioning - adverse effects Transplantation Conditioning - mortality Transplantation Conditioning - trends Transplantation, Autologous - adverse effects Transplantation, Autologous - mortality Transplantation, Autologous - trends Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!